Cymbalta significantly reduces pain in study patients

Eli Lilly and Co. reported that 31% of 236 patients showed a 50% reduction in chronic lower-back pain after taking once-daily doses of Cymbalta in a study of the depression drug. Only 19% of patients who got placebo reported the same effect, according to the study. The company, which presented the data during a conference in Spain, is seeking FDA approval to market Cymbalta for treating chronic pain.

View Full Article in:

Wall Street Journal (tiered subscription model), The · Indianapolis Business Journal

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ